HomeCompareVMCS vs CHD

VMCS vs CHD: Dividend Comparison 2026

VMCS yields 27397.26% · CHD yields 1.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VMCS wins by $1.1972107461873825e+21M in total portfolio value
10 years
VMCS
VMCS
● Live price
27397.26%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.1972107461873825e+21M
Annual income
$1,188,675,931,216,516,700,000,000,000.00
Full VMCS calculator →
CHD
CHD
● Live price
1.27%
Share price
$93.91
Annual div
$1.19
5Y div CAGR
23.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.4K
Annual income
$1,292.51
Full CHD calculator →

Portfolio growth — VMCS vs CHD

📍 VMCS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVMCSCHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VMCS + CHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VMCS pays
CHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VMCS
Annual income on $10K today (after 15% tax)
$2,328,767.12/yr
After 10yr DRIP, annual income (after tax)
$1,010,374,541,534,039,100,000,000,000.00/yr
CHD
Annual income on $10K today (after 15% tax)
$107.94/yr
After 10yr DRIP, annual income (after tax)
$1,098.63/yr
At 15% tax rate, VMCS beats the other by $1,010,374,541,534,039,100,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VMCS + CHD for your $10,000?

VMCS: 50%CHD: 50%
100% CHD50/50100% VMCS
Portfolio after 10yr
$598605373093691260928.00M
Annual income
$594,337,965,608,258,360,000,000,000.00/yr
Blended yield
99.29%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CHD right now

VMCS
No analyst data
CHD
Analyst Ratings
18
Buy
15
Hold
1
Sell
Consensus: Buy
Price Target
$98.40
+4.8% upside vs current
Range: $82.00 — $110.00
Altman Z
4.9
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VMCS buys
0
CHD buys
0
No recent congressional trades found for VMCS or CHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVMCSCHD
Forward yield27397.26%1.27%
Annual dividend / share$2.00$1.19
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%23.1%
Portfolio after 10y$1.1972107461873825e+21M$26.4K
Annual income after 10y$1,188,675,931,216,516,700,000,000,000.00$1,292.51
Total dividends collected$1.1966488951365923e+21M$5.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: VMCS vs CHD ($10,000, DRIP)

YearVMCS PortfolioVMCS Income/yrCHD PortfolioCHD Income/yrGap
1← crossover$2,750,426$2,739,726.03$10,856$156.32+$2.74MVMCS
2$707,187,234$704,244,277.92$11,811$195.24+$707.18MVMCS
3$169,985,380,233$169,228,689,893.21$12,883$244.38+$169985.37MVMCS
4$38,197,967,914,920$38,016,083,558,069.93$14,091$306.64+$38197967.90MVMCS
5$8,024,720,272,857,223$7,983,848,447,188,260.00$15,463$385.88+$8024720272.84MVMCS
6$1,576,124,710,628,837,000$1,567,538,259,936,880,000.00$17,033$487.17+$1576124710628.82MVMCS
7$289,423,013,630,119,900,000$287,736,560,189,747,040,000.00$18,843$617.36+$289423013630119.88MVMCS
8$49,689,985,921,465,780,000,000$49,380,303,296,881,550,000,000.00$20,947$785.72+$49689985921465776.00MVMCS
9$7,976,462,589,593,958,000,000,000$7,923,294,304,657,990,000,000,000.00$23,419$1,004.91+$7976462589593958400.00MVMCS
10$1,197,210,746,187,382,400,000,000,000$1,188,675,931,216,516,700,000,000,000.00$26,350$1,292.51+$1.1972107461873825e+21MVMCS

VMCS vs CHD: Complete Analysis 2026

VMCSStock

InnovaQor, Inc. develops and provides information technology solutions and services to healthcare and laboratory customers in the United States. It offers electronic health records product for behavioral health providers and substance abuse centers, as well as a related product for ambulatory practices; and laboratory information system product for small to mid-size clinical laboratories. The company also develops business intelligence and aggregated data analytics in real-time to allow decision support. In addition, it provides virtual chief information officer (vCIO) services, such as life-cycle project and program management services; consulting, and outsourced product design, development, enhancement, and testing services; and IT managed services, such as backups and diagnostics tools to identify breaks in security and solutions, as well as designs and implements security policies, solutions that integrate physical surveillance and access control to cyber security, and systems. The company was formerly known as VisualMED Clinical Solutions Corp. and changed its name to InnovaQor, Inc. in September 2021. InnovaQor, Inc. was founded in 1999 and is based in West Palm Beach, Florida.

Full VMCS Calculator →

CHDConsumer Staples

Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; cold shortening and relief products under the ZICAM brand; and oral care products under the THERABREATH brand. Its specialty products include animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast-based prebiotic. The company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. The company was founded in 1846 and is headquartered in Ewing, New Jersey.

Full CHD Calculator →
📬

Get this VMCS vs CHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VMCS vs SCHDVMCS vs JEPIVMCS vs OVMCS vs KOVMCS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.